²é¿´: 5952  |  »Ø¸´: 154
±¾Ìû²úÉú 1 ¸ö BM-EPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

»ÆÍª

ľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] ÉúÎï²ÄÁϾ­µäBiomaterials for clinical applications ÒÑÓÐ1È˲ÎÓë

Biomaterials for clinical applicationsÊÇÉúÎï²ÄÁÏ·½ÃæµÄ¾­µäÖ®×÷£¬ÓõÃÉϵĸϽôÏÂÔØ°É£¬²»ÒªÁßϧºÃÆÀŶ£¬Ç×Ϊ·½±ã´ó¼Ò£¬ÏÖ°ÑĿ¼±à¼­ºÃ¡£
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 TheWorldwideBurden ofDisease . . . . . . . . . . . . . . . . 2
1.2 Global Population Aging and the Burden of Disease . . . . . . 8
1.3 The Global Economic Impact of Disease . . . . . . . . . . . . 10
1.4 TheRoleofNovelBiomaterials inAlleviatingDisease . . . . . 15
1.5 Practical Considerations for Modern Biomaterials . . . . . . . . 18
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2 Coronary Artery Disease . . . . . . . . . . . . . . . . . . . . . . . . 23
2.1 Historical Perspective on Coronary Artery Disease . . . . . . . 23
2.2 Pathology of Coronary Artery Disease . . . . . . . . . . . . . . 24
2.3 Biomaterials as Bioactive Stents . . . . . . . . . . . . . . . . . 33
2.4 Biomaterials as Degradable Stents . . . . . . . . . . . . . . . . 38
2.5 Biomaterials for Cardiac Regeneration . . . . . . . . . . . . . . 42
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3 Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.1 Pathology ofStroke . . . . . . . . . . . . . . . . . . . . . . . . 51
3.2 Biomaterials forBrain Imaging . . . . . . . . . . . . . . . . . 62
3.3 Biomaterials for Nerve Regeneration . . . . . . . . . . . . . . 68
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4 Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.1 Historical Perspective on Pneumonia . . . . . . . . . . . . . . 75
4.2 Pathology of Pneumonia . . . . . . . . . . . . . . . . . . . . . 76
4.3 Biomaterials asNovelAntibioticCarriers . . . . . . . . . . . . 85
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
5 COPD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
5.1 Historical Perspective on COPD . . . . . . . . . . . . . . . . . 99
5.2 Pathology ofCOPD . . . . . . . . . . . . . . . . . . . . . . . 100
5.3 Biomaterials for Lung Regeneration . . . . . . . . . . . . . . . 107
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
6 Diarrheal Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
6.1 Pathology ofDiarrhea . . . . . . . . . . . . . . . . . . . . . . 122
6.2 Complexity and Cost of Current Diagnostic Methods . . . . . . 133
6.3 Biomaterials as Low-Cost Diagnostic Devices . . . . . . . . . . 136
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
7 HIV/AIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
7.1 Pathogenesis of HIV/AIDS . . . . . . . . . . . . . . . . . . . . 148
7.2 Biomaterials as Vaccine Adjuvants . . . . . . . . . . . . . . . . 156
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
8 Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
8.1 Pathology of Tuberculosis . . . . . . . . . . . . . . . . . . . . 168
8.2 Biomaterials forSustainedDrugRelease . . . . . . . . . . . . 175
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
9 Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
9.1 Pathology of Lung Cancer . . . . . . . . . . . . . . . . . . . . 183
9.2 Biomaterials forPassiveTargetedDrugDelivery . . . . . . . . 190
9.3 Biomaterials forActiveTargetedDrugDelivery . . . . . . . . . 200
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
10 Traumatic Injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . 213
10.1 Clinical Necessity for Wound Closure Technologies . . . . . . 214
10.2 Fibrin-Based Biomaterials for Wound Closure . . . . . . . . . . 220
10.3 Cyanoacrylate-Based Biomaterials as Tissue Glues . . . . . . . 225
10.4 CrosslinkedProtein-BasedBiomaterials asTissueGlues . . . . 232
10.5 Polyethylene Glycol (PEG)-Based Biomaterials
for Wound Closure . . . . . . . . . . . . . . . . . . . . . . . . 238
10.6 Emerging Biomaterials for Wound Closure . . . . . . . . . . . 245
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 249
11 Prematurity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259
11.1 LungSurfactant andRespiratoryDistress inInfants . . . . . . . 259
11.2 Biomaterials as Synthetic Surfactants for the Lungs . . . . . . . 267
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 273
12 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279

[ Last edited by »ÆÍª on 2012-10-28 at 08:47 ]
»Ø¸´´ËÂ¥

» ±¾Ìû¸½¼þ×ÊÔ´Áбí

  • »¶Ó­¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
    ±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com
  • ¸½¼þ 1 : Biomaterialsforclinicalapplications.pdf
  • 2012-10-27 19:04:12, 6.95 M

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

templefire

½ð³æ (ÕýʽдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡Â¥Ö÷ÕæÊǸöºÃÈË£¡£¡
91Â¥2013-01-03 12:24:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 155 ¸ö»Ø´ð
¼òµ¥»Ø¸´
shent3Â¥
2012-10-28 22:01   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-28 22:48   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-29 10:22   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
2012-10-29 12:44   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ÓÅÓö7Â¥
2012-10-30 13:14   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
guonick8Â¥
2012-10-30 21:55   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xipha9Â¥
2012-10-31 15:09   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
imhnwam10Â¥
2012-10-31 17:06   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
chambinsg11Â¥
2012-10-31 17:49   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wtiger12Â¥
2012-10-31 18:39   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
liuweische13Â¥
2012-10-31 23:18   »Ø¸´  
ÎåÐÇºÃÆÀ  ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼²©] ¶«»ªÀí¹¤´óѧ»¯²Äרҵ26½ì˶ʿ²©Ê¿ÉêÇë +8 zlingli 2026-03-13 8/400 2026-03-19 16:32 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á +4 Doleres 2026-03-19 4/200 2026-03-19 15:27 by ¶¡¶¡*
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷°²½»Í¨´óѧ²ÄÁϹ¤³Ìרҵ 282·ÖÇóµ÷¼Á +5 ·ãÇÅZL 2026-03-18 7/350 2026-03-19 14:52 by ¹¦·ò·è¿ñ
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +6 Ð÷ÐÒÓë×Ó 2026-03-17 6/300 2026-03-19 13:27 by houyaoxu
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338 +5 ²Ì´óÃÀÅ® 2026-03-13 5/250 2026-03-19 10:44 by ÊÇСÁõѽ¡«
[¿¼ÑÐ] 267Ò»Ö¾Ô¸ÄϾ©¹¤Òµ´óѧ0817»¯¹¤Çóµ÷¼Á +10 SUICHILD 2026-03-12 10/500 2026-03-19 09:51 by Delta2012
[¿¼ÑÐ] 311Çóµ÷¼Á +4 ¶¬Ê®Èý 2026-03-18 4/200 2026-03-18 21:47 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] 295Çóµ÷¼Á +3 Ò»Ö¾Ô¸¾©Çø211 2026-03-18 5/250 2026-03-18 17:03 by zhaoqian0518
[¿¼ÑÐ] 298-Ò»Ö¾Ô¸Öйúũҵ´óѧ-Çóµ÷¼Á +7 ÊÖ»úÓû§ 2026-03-17 7/350 2026-03-18 14:34 by vgtyfty
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷ÄϽ»´ó£¬Çóµ÷¼Á +4 ²Ä»¯ÖðÃÎÈË 2026-03-18 4/200 2026-03-18 14:22 by 007_lilei
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] 26¿¼ÑÐÇóµ÷¼Á +6 ؼºêSir 2026-03-13 6/300 2026-03-17 16:13 by ×íÔÚ·çÀï
[¿¼²©] 26É격 +4 °Ë6°Ë68 2026-03-16 4/200 2026-03-17 13:00 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] ¶«ÄÏ´óѧ364Çóµ÷¼Á +5 JasonYuiui 2026-03-15 5/250 2026-03-16 21:28 by ľ¹Ï¸à
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐʦ·¶071000£¬325Çóµ÷¼Á +6 RuitingC 2026-03-12 6/300 2026-03-16 14:50 by ¿Éµ­²»¿ÉÍü
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] Öпƴó²ÄÁÏÓ뻯¹¤319Çóµ÷¼Á +3 ÃÏöβÄÁÏ 2026-03-14 3/150 2026-03-14 20:10 by ms629
[¿¼ÑÐ] 304Çóµ÷¼Á +7 7712b 2026-03-13 7/350 2026-03-13 21:42 by peike
[¿¼ÑÐ] 308Çóµ÷¼Á +3 ÊÇLupa°¡ 2026-03-12 3/150 2026-03-13 14:30 by Çóµ÷¼Ázz
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û